Andrea Navarria

2.1k total citations · 1 hit paper
21 papers, 1.4k citations indexed

About

Andrea Navarria is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Andrea Navarria has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Andrea Navarria's work include Diabetes Treatment and Management (10 papers), Diabetes Management and Research (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). Andrea Navarria is often cited by papers focused on Diabetes Treatment and Management (10 papers), Diabetes Management and Research (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). Andrea Navarria collaborates with scholars based in Denmark, Italy and United States. Andrea Navarria's co-authors include Vanita R. Aroda, Ildiko Lingvay, Adie Viljoen, Richard E. Pratley, J Lüdemann, Filippo Drago, Ronald S. Duman, Bhavya Voleti, Rune Viig Overgaard and Steen H. Ingwersen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Biological Psychiatry.

In The Last Decade

Andrea Navarria

19 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial

2018 559 citations Richard E. Pratley, Vanita R. Aroda et al. The Lancet Diabetes & Endocrinology profile →

Peers

Andrea Navarria

EDM

PHARM

CMN

SURGE

Karen Sundell United States

Giuseppe Gambina Italy

Marina Zvartau‐Hind United States

J. Jacob Kulstad United States

Silvia Maioli Sweden

Sharon Sawchak United States

M. L. Rao Germany

D Bouthillier Canada

Benjamin M. Terry United States

Jorge Alsina‐Fernandez United States

Karen Sundell United States

Andrea Navarria

132 ×0.2

EDM

370 ×0.6

371 ×0.9

PHARM

75 ×0.2

CMN

93 ×0.5

SURGE

Citations per year, relative to Andrea Navarria Andrea Navarria (= 1×) peers Karen Sundell

Countries citing papers authored by Andrea Navarria

Since Specialization

Citations

This map shows the geographic impact of Andrea Navarria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Navarria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Navarria more than expected).

Fields of papers citing papers by Andrea Navarria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Navarria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Navarria. The network helps show where Andrea Navarria may publish in the future.

Co-authorship network of co-authors of Andrea Navarria

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Navarria. A scholar is included among the top collaborators of Andrea Navarria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Navarria. Andrea Navarria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lingvay, Ildiko, et al.. (2025). Efficacy and Hypoglycemia Profile of Once-weekly Insulin Icodec vs Once-daily Comparators Across Demographic Subgroups. The Journal of Clinical Endocrinology & Metabolism. 110(11). e3596–e3606. 3 indexed citations

Eto, Takashi, Miwa Haranaka, Niels Rode Kristensen, et al.. (2024). Pharmacological characteristics of once‐weekly insulin icodec in Japanese individuals with type 1 diabetes. Journal of Diabetes Investigation. 16(3). 434–441. 2 indexed citations

Desouza, Cyrus, et al.. (2024). 841-P: Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes by Ethnicity and Race—ONWARDS 1–5. Diabetes. 73(Supplement_1).

Clément, Karine, et al.. (2023). Long-term Body Composition in Patients With POMC or LEPR Deficiency Obesity Following Setmelanotide. Endocrine Abstracts. 1 indexed citations

Clément, Karine, et al.. (2023). Weight Outcomes With Setmelanotide Over 3 Years in Patients With POMC or LEPR Deficiency Obesity. Endocrine Abstracts.

Overgaard, Rune Viig, CHRISTIN L. HERTZ, Steen H. Ingwersen, Andrea Navarria, & Daniel J. Drucker. (2021). Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes. Cell Reports Medicine. 2(9). 100387–100387. 70 indexed citations

Overgaard, Rune Viig, et al.. (2021). Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials. Clinical Pharmacokinetics. 60(10). 1335–1348. 78 indexed citations

Meier, Juris J., Charlotte Granhall, Andrea Navarria, et al.. (2021). Effect of upper gastrointestinal disease on the pharmacokinetics of oral semaglutide in subjects with type 2 diabetes. Diabetes Obesity and Metabolism. 24(4). 684–692. 10 indexed citations

Meier, Juris J., Charlotte Granhall, Andrea Navarria, et al.. (2019). 1013-P: Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects with Type 2 Diabetes. Diabetes. 68(Supplement_1). 10 indexed citations

10.

Pratley, Richard E., Vanita R. Aroda, Ildiko Lingvay, et al.. (2018). Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. The Lancet Diabetes & Endocrinology. 6(4). 275–286. 559 indexed citations breakdown →

11.

Bækdal, Tine A., et al.. (2018). A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide. Expert Opinion on Drug Metabolism & Toxicology. 14(8). 869–877. 45 indexed citations

12.

Gozzo, Lucia, Andrea Navarria, Laura Longo, et al.. (2017). Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network. Clinical Drug Investigation. 37(11). 1067–1081. 6 indexed citations

13.

Leggio, Gian Marco, Maria Vincenza Catania, Daniela Puzzo, et al.. (2016). The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß 1-42 oligomers in mice. Pharmacological Research. 106. 10–20. 30 indexed citations

14.

Gozzo, Lucia, Andrea Navarria, Laura Longo, et al.. (2016). Linking the Price of Cancer Drug Treatments to Their Clinical Value. Clinical Drug Investigation. 36(7). 579–589. 7 indexed citations

15.

Navarria, Andrea, Eric S. Wohleb, Bhavya Voleti, et al.. (2015). Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors. Neurobiology of Disease. 82. 254–261. 100 indexed citations

16.

Navarria, Andrea, Lucia Gozzo, Laura Longo, et al.. (2014). Do the Current Performance-Based Schemes in Italy Really Work? “Success Fee”: A Novel Measure for Cost-Containment of Drug Expenditure. Value in Health. 18(1). 131–136. 54 indexed citations

17.

Navarria, Andrea, Alessandra Tamburella, Fabio Arturo Iannotti, et al.. (2014). The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. Pharmacological Research. 87. 151–159. 64 indexed citations

18.

Voleti, Bhavya, Andrea Navarria, Rong-Jian Liu, et al.. (2013). Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses. Biological Psychiatry. 74(10). 742–749. 216 indexed citations

19.

Tamburella, Alessandra, Gian Marco Leggio, Vincenzo Micale, et al.. (2012). Behavioural and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant. The International Journal of Neuropsychopharmacology. 16(4). 813–823. 12 indexed citations

20.

Tamburella, Alessandra, Vincenzo Micale, Andrea Navarria, & Filippo Drago. (2009). Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: Behavioral and neurochemical studies in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33(7). 1205–1210. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact